## AMD: Advanced Micro Devices, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.53 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: declining volume (57% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($197.89)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. AMD Stock: Jumps as Trump Approves Nvidia’s China Chip Sales — Is AMD Next?**
- Source: CoinCentral | 20251209T100817 | Bullish | Relevance: 99%
- AMD stock rose 2% after President Trump approved Nvidia's H200 AI chip sales to China, stating that AMD and other American companies would receive similar export approval. This development is significant as AMD's previous AI chip sales to China were heavily restricted, blocking access to a major market for its MI300 chips. While a 25% revenue share with the U.S. government is expected, investors are focused on the potential for new revenue streams and market access.

**2. Is Advanced Micro Devices, Inc. (AMD) one of the best augmented reality stocks to buy right now?**
- Source: MSN | 20251208T200752 | Bullish | Relevance: 99%
- The article discusses whether Advanced Micro Devices (AMD) is a top augmented reality stock to consider. It would likely delve into AMD's current involvement in augmented reality technology, its financial performance, and future prospects within the AR market to justify its position as a potential investment.

**3. Insider Unloading: Paul Darren Grasby Sells $2.19M Worth Of Advanced Micro Devices Shares**
- Source: Benzinga | 20251209T150748 | Neutral | Relevance: 98%
-  Paul Darren Grasby, EVP & CSO at Advanced Micro Devices (NASDAQ: AMD), sold 10,000 shares of the company's stock for a total of $2,187,700, according to a recent SEC filing. This transaction occurred on December 8, and the article provides an overview of AMD's financial performance and the significance of insider transactions. Insider sells do not necessarily indicate a negative outlook for the stock but are important for investors to consider as part of a broader analysis.

**4. TD Cowen Reiterates Buy on AMD, Calls Helios a Major AI Inflection Point**
- Source: Finviz | 20251206T094407 | Bullish | Relevance: 98%
- TD Cowen has reiterated a "Buy" rating on Advanced Micro Devices (AMD) with a $290 price target, identifying it as a top AI stock. The firm believes AMD's "Helios" AI rack-scale architecture will be a major AI inflection point, establishing the company as a winner in the AI compute market. Despite concerns about a volatile AI spending environment, analysts see the recent pullback in shares as an attractive entry point ahead of the Helios launch, predicting significant EPS growth.

**5. AMD Stock Pops After U.S. Hints at China AI Chip Reopening**
- Source: TradingView | 20251209T110740 | Bullish | Relevance: 98%
- AMD shares rose after the U.S. indicated it would approve Nvidia's AI chip sales to China under a revenue-share model, sparking hopes for similar approval for AMD's MI300 processors. This potential market access could unlock significant revenue for AMD, despite a 25% fee, as investors prioritize market expansion over short-term profitability. Clarity from the Commerce Department regarding AMD's export eligibility is anticipated as the next catalyst for its stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Roth Capital | $300 | $300 | 0% |
| 2025-11-12 | Piper Sandler | $280 | $280 | 0% |
| 2025-11-12 | Wells Fargo | $345 | $300 | +15% |
| 2025-11-12 | B of A Securiti | $300 | $300 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Roth Capital | main | Buy |
| 2025-11-12 | Piper Sandler | reit | Overweight |
| 2025-11-12 | Wells Fargo | main | Overweight |
| 2025-11-12 | B of A Securiti | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 9 ($2.83M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.6% (+0.9%)
- Blackrock Inc.: 8.4% (-0.9%)
- State Street Corpora: 4.5% (+2.4%)
- Geode Capital Manage: 2.3% (+1.7%)
- Morgan Stanley: 1.8% (+1.5%)

### Key Risks

1. High beta (1.93) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.53 indicates undervaluation relative to growth. Forward P/E 34.3x attractive for 62% earnings growth. Balance sheet: strong liquidity (2.3x), low leverage (D/E 0.26), $1.9B free cash flow. Revenue growth strong at 31% YoY. Analyst sentiment positive (3 raises, avg +8%). Insider selling cluster ($2.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $360.0B |
| Beta | 1.93 |
| 52W Range | $76.48 - $267.08 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.53 |
| Forward P/E | 34.3 |
| Current P/E | 55.8 |
| YoY Growth | 62.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -8.1% to -3.7% (+4.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.7pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.4%) - potential reversal signal. Underperforming sector by 4.9pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.44x) but short-term weakness (below SMA20). MACD histogram bearish (-0.73), momentum weakening. RSI neutral at 48. Volume at 57% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.71% (CS: 26) | Weak |
| RSI_14 | 48.5 | Neutral |
| MACD Histogram | -0.73 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 1.439x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $221.11
- **Stop Loss:** $197.89 (10.5% risk)
- **Target:** $267.55 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 51
- **Position Value:** $11,276.61
- **Portfolio %:** 11.28%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-03 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.20 | +2.5% |
| 2025Q2 | $0.48 | $0.48 | -0.5% |
| 2025Q1 | $0.93 | $0.96 | +2.8% |
| 2024Q4 | $1.09 | $1.09 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*